M&T Bank
EW icon

M&T Bank’s Edwards Lifesciences EW Stock Holding History

M&T Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,000
Closed -$12K – 2161
2014
Q3 		$12K Buy
+3,000
New +$47.4K ﹤0.01% 2184

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

M&T Bank's EW Position: Q1 2026 in Review

M&T Bank reduced its Edwards Lifesciences (EW) stake by 4.1% in Q1 2026, selling an estimated $122K and leaving 34,271 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #515.

M&T Bank first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.4M in Q3 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • M&T Bank held 34,271 shares of Edwards Lifesciences worth $2.74M as of Q1 2026.
  • M&T Bank sold 1,483 Edwards Lifesciences shares in Q1 2026, an estimated $122K.
  • Edwards Lifesciences made up 0.01% of M&T Bank's portfolio in Q1 2026, its #515 holding.
  • M&T Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
  • M&T Bank's Edwards Lifesciences position peaked at $12.4M in Q3 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.